Homeproductpurchase

About Lifespan Technologies

 

Michael Mostert
President and CEO:
mm@lifespantech.com

Justin Chafe
Marketing Manager
justin@lifespantech.com

Lifespan Technologies was founded in 1992 to develop medical diagnostic and assay products. Lifespan has acquired exclusive rights to a novel new heparin binding protein. This technology has potential applications for:

Clinical Diagnostics
       - Therapeutic drug monitoring
       - Heparin clearance: Determination of 
          whether patients are at risk of 
          heparinization
       - Determining predisposition of patients 
          to heparin induced 
          thrombocytopenia.

Pharmaceutical - Pharmacodynamic and pharmacokinetic studies - Pharmaceutical quality control

Medical Device - Quality control of heparin coated devices - In-process tesing


contacttechinfo